This assay is used to determine immune status for Hepatitis B as ¡Ý10 mIU/mL as per CDC Guidelines. Hepatitis B is a liver disease that is caused by the hepatitis B virus (HBV). Hepatitis B is a bloodborne pathogen and exposure to the blood of an infected person may result in infection.
Abnormal results may require further evaluation by your physician.
Presence of anti-HBs is an indicator of clinical recovery and subsequent immunity to hepatitis B virus. This test is useful for evaluation of possible immunity in individuals who are at increased risks for exposure to the hepatitis B (ie, hemodialysis unit personnel, venipuncturists, etc). Evaluate the need for hepatitis B immune globulin after needlestick injury; evaluate the need for hepatitis B vaccine and follow immune status after hepatitis B vaccine.
Hepatitis B Surface Antibody Immunity, Quantitative
No fasting required.
Estimated turnaround for results is 3 business days. If confirmation testing is required, the estimated time may be extended.